Cellectis S.A. Files Form 6-K with April 8 Press Release
Ticker: CLLS · Form: 6-K · Filed: Apr 8, 2024 · CIK: 1627281
Sentiment: neutral
Topics: reporting, foreign-private-issuer
Related Tickers: CLLS
TL;DR
Cellectis (CLLS) filed a 6-K on 4/8, including a press release. Stay tuned for updates.
AI Summary
Cellectis S.A. filed a Form 6-K on April 8, 2024, reporting information for the month of April 2024. The filing includes a press release dated April 8, 2024, as Exhibit 99.1. Cellectis S.A. is a foreign private issuer based in Paris, France, and files annual reports under Form 20-F.
Why It Matters
This filing indicates ongoing reporting activity for Cellectis S.A., providing investors with updated information through a press release.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- April 8, 2024 (date) — Date of press release and filing
- Paris, France (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to report information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What specific exhibit is included with this 6-K filing?
This 6-K filing includes Exhibit 99.1, which is a Press Release dated April 8, 2024.
Does Cellectis S.A. file annual reports under Form 20-F or 40-F?
Cellectis S.A. indicates that it files annual reports under cover of Form 20-F.
Where is Cellectis S.A. headquartered?
Cellectis S.A. is headquartered at 8, rue de la Croix Jarry, 75013 Paris, France.
What is the Commission File Number for Cellectis S.A.'s filings?
The Commission File Number for Cellectis S.A. is 001-36891.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-04-08 16:35:07
Filing Documents
- f6k_040824.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-24-001900.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: April 8, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer